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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORMultiple extranodal organ involvement and
increase of serum ß-HCG in a case of primary
mediastinal large B-cell lymphomaTo the Editor,
Primary mediastinal large B-cell lymphoma (PMLBCL) is a
distinct subtype of diffuse large B-cell lymphoma. It is
usually diagnosed by pathological findings of a mediastinal
mass. Multiple extranodal organs’ involvement at the time
of diagnosis and b-HCG (beta human chorionic gonado-
tropin) expression is rare.
A 51-year-old Taiwanese male had been suffering from
progressive dyspnea for 2 months. A chest X-ray (Fig. 1A)
showed a huge heart with a water bottle sign. Cardiac echo
and positron emission tomography scan (Fig. 1CeF) showed
tumors involving the anterior mediastinum, thoracic cavity,
stomach (Fig. 1E, arrow), and bilateral adrenal glands
(Fig. 1F, arrow). Serology tests showed an increased level of
lactate dehydrogenase (387 IU/L), b-HCG (10.02 mIU/mL),
CA-125 (298.07 U/mL), tissue polypeptide antigen
(386.03 U/mL), but normal b2-microglobulin (160 mg/dL)
and AFP (2.88 ng/mL). He received computed tomography-
guided right adrenal gland biopsy and esophagogas-
troduodenoscopy for tissue proof instead of anterior medi-
astinal mass. Both the pathology of the adrenal gland and
gastric lesion showed an infiltration of large neoplastic B
cells compartmentalized by fine delicate bands of fibrosis,
and immunohistochemistry was positive for CD20 and LCA
(leukocyte common antigen), and negative for CK and CD3.
PMLBCL with multiple organs’ (heart, stomach, and bilateral
adrenal glands) involvement was diagnosed. The patient
accepted chemotherapy with an R-CHOP regimen. After six
courses of chemotherapy, complete remission was achieved
with disappearance of the mediastinal mass on chest X-ray
(Fig. 1B) and normalized tumor markers.Conflicts of interest: All authors declare no conflicts of interest.
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[1] in 1980, is an uncommon and distinct subtype of
diffuse large B-cell lymphoma. The case we reported
raises several interesting points. First, increasing serum
level of ß-HCG, a tumor marker of nonhematological tu-
mors, germ-cell tumors, could detract clinicians from
making a diagnosis of primary mediastinal lymphoma. We
reviewed the related literatures and found that b-HCG is
rarely expressed in lymphomas. Only six cases of lym-
phomasdtwo PMLBCLs [2], three adult T cell-type malig-
nant lymphomas [3], and one anaplastic large cell
lymphoma [4] with b-HCG expression in immunohistoche-
mistrydhave been reported. However, only the anaplastic
large cell lymphoma reported a raised serum b-HCG level.
This is the first reported case of a PMLBCL with raised
serum b-HCG level. Second, although PMLBCL seldom
presents with extrathoracic structure involvement at the
time of diagnosis [5], this case involved multiple extra-
nodal organs including the heart, stomach, and bilateral
adrenal glands at the time of diagnosis. A diagnosis of
PMLBCL should be kept in mind when dealing with similar
cases where the involvement of multiple extrathoracic
and extranodal organs is indicated.
In conclusion, PMLBCL may present with multiple
extranodal organs’ involvement and increased levels of a
nonhematologic tumor marker. Although the expression of
nonhematologic tumor marker, b-HCG, is rare in lym-
phomas, one should summarily not rule out the possibility
of PMLBCL. Careful diagnosis is necessary to differentiate
germ cell tumors and other metastatic malignancies from
PMLBCL.y Elsevier Taiwan LLC. All rights reserved
Figure 1. (A) Initial chest X-ray at the time of diagnosis shows a mediastinal mass with water bottle heart sign. (B) Chest X-ray
after treatment reveals normal heart size and disappearance of the mediastinal mass. (C) Cardiac echo shows pericardial effusion
and a suspected tumor encasing the aorta (arrow). (DeF) Positron emission tomography scan shows lesions over multiple medi-
astinal lymph nodes, cardiac wall, stomach (E, arrow), and bilateral adrenal glands (F, arrows).
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